![]() |
Volumn 13, Issue 4, 2013, Pages 543-546
|
Novel pathways in the yin-yang of immunomodulation Editorial overview
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADVANCED GLYCATION END PRODUCT;
ANTINEOPLASTIC AGENT;
CALCINEURIN INHIBITOR;
CHEMOKINE RECEPTOR CCR2;
ESTROGEN;
GLUCOCORTICOID;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
LEUKOTRIENE B4;
LIPOCORTIN 1;
MESSENGER RNA;
MICRORNA;
MONOCYTE CHEMOTACTIC PROTEIN 1;
PROTEIN S 100;
REACTIVE OXYGEN METABOLITE;
ADAPTIVE IMMUNITY;
ADIPOSE TISSUE;
AUTOIMMUNE DISEASE;
B LYMPHOCYTE;
CANCER GROWTH;
CARDIOVASCULAR DISEASE;
CELL CONTACT;
CELLULAR IMMUNITY;
DENDRITIC CELL;
DRUG RESISTANCE;
EDITORIAL;
EPIGENETICS;
FIBROBLAST;
GRAFT REJECTION;
HOST RESISTANCE;
HUMAN;
HUMORAL IMMUNITY;
IMMUNOMODULATION;
IMMUNOREGULATION;
IMMUNOSTIMULATION;
IMMUNOSUPPRESSIVE TREATMENT;
INFLAMMATION;
KIDNEY FIBROSIS;
MACROPHAGE;
MAST CELL;
MEMBRANE MICROPARTICLE;
METASTASIS;
MONOCYTE;
NEUTROPHIL;
OBESITY;
PRIORITY JOURNAL;
RHEUMATOID ARTHRITIS;
T LYMPHOCYTE;
TH1 CELL;
TH17 CELL;
TUBERCULOSIS;
TUMOR ASSOCIATED LEUKOCYTE;
|
EID: 84885956254
PISSN: 14714892
EISSN: 14714973
Source Type: Journal
DOI: 10.1016/j.coph.2013.06.010 Document Type: Editorial |
Times cited : (5)
|
References (0)
|